肺胞性喘息の英語

gｏｂ−５発現細胞を用いる気管支喘息、慢性閉塞性肺疾患などの呼吸器疾患または鼻炎の予防・治療剤のスクリーニング方法。例文帳に追加

A screening method for prophylactic/therapeutic agents for rhinitis or respiratory diseases including bronchial asthma and chronic obstructive pulmonary diseases involves using the gob-5 expression cell. - 特許庁

該組成物は、気道の杯細胞過形成を顕著に抑制する効果があり、感冒剤として、また急性又は慢性気管支炎、慢性閉塞性肺疾患、気管支拡張症、気管支喘息、肺結核、塵肺症、肺気腫、びまん性汎気管支炎等の慢性気道疾患における急性呼吸器感染時の症状の治療に有用である。例文帳に追加

The composition has an efficacy of remarkably suppressing goblet cell hyperplasia of respiratory tract and useful for drug for common cold, treatment for acute respiratory disease symptom in chronic airways disease such as acute or chronic bronchitis, chronic obstructive pulmonary disease, bronchiectasis, bronchial asthma, pulmonary tuberculosis, pneumoconiosis, pulmonary emphysema, diffuse panbronchitis, etc. - 特許庁

抗炎症性ステロイドを患部に効率的にターゲッティングし、薬物徐放性に優れ、かつ気管支肺胞浸潤抑制効果及び気道過敏性抑制効果に優れた気管支喘息治療剤及びアレルギー性鼻炎治療剤を提供すること。例文帳に追加

To obtain a therapeutic agent for bronchial asthma and a therapeutic agent for allergic rhinitis, which efficiently makes an anti-inflammatory steroid target the affected part and has an excellent medicine sustained release, inhibitory effect on bronchoalveolar infiltration and inhibitory effect on airway hyperreactivity. - 特許庁

ムチン合成を調節する方法、および疾患（例えば、喘息および慢性気管支炎、炎症性肺疾患、嚢胞性線維症ならびに急性または慢性の呼吸器感染疾患を含む、慢性閉塞性肺疾患（ＣＯＰＤ））に関連したムチン過剰産生を制御する際の化合物の治療適用を提供すること。例文帳に追加

To provide a method of controlling the mucin synthesis and a therapeutic application of a compound for controlling the excessive formation of the mucin relating to diseases (for example, asthma and chronic bronchitis, inflammatory pulmonary diseases, cystic fibrosis and chronic obstructive pulmonary disease(COPD) including acute or chronic respiratory tract infections). - 特許庁

アレルギー性疾患（アレルギー性鼻炎、アレルギー性結膜炎、アトピー性皮膚炎、気管支喘息、食物アレルギー等）、全身性肥満細胞症、全身性肥満細胞活性化障害、アナフィラキシーショック、気道収縮、蕁麻疹、湿疹、痒みを伴う疾患、炎症、慢性閉塞性肺疾患、虚血再灌流障害、脳血管障害、慢性関節リウマチ、胸膜炎、潰瘍性大腸炎等の疾患の予防および／または治療に有用な化合物の提供。例文帳に追加

To provide compounds useful for prevention and/or treatment of diseases such as allergic diseases (such as allergic rhinitis, allergic conjunctivitis, atopic dermatitis, bronchial asthma and food allergy), systemic mast cell disease, systemic mast cell activation failure, anaphylactic shock, respiratory tract contraction, urticaria, eczema, diseases associated with itch, inflammation, chronic obstructive pulmonary disease, ischemic reperfusion injury, cerebrovascular disorder, rheumatoid arthritis, pleuritis, ulcerative colitis. - 特許庁